Selected article for: "coronavirus disease and International license"

Author: Sally M. ELGhamrawy; Abou Ellah Hassanien
Title: Diagnosis and Prediction Model for COVID19 Patients Response to Treatment based on Convolutional Neural Networks and Whale Optimization Algorithm Using CT Images
  • Document date: 2020_4_21
  • ID: jir00627_18
    Snippet: In the proposed model, different AI techniques are used based on their functionality on six main phases, as shown in figure 2 , namely, the pre-processing, segmentation, feature selection, classification, Prediction and diagnosis recommendation phase. The AIMDP model has two main modules: The Diagnosing Module (DM) which is concerned with detecting the patients with Coronavirus (COVID 19) Disease and distinguish it from other viral pneumonias, by.....
    Document: In the proposed model, different AI techniques are used based on their functionality on six main phases, as shown in figure 2 , namely, the pre-processing, segmentation, feature selection, classification, Prediction and diagnosis recommendation phase. The AIMDP model has two main modules: The Diagnosing Module (DM) which is concerned with detecting the patients with Coronavirus (COVID 19) Disease and distinguish it from other viral pneumonias, by detecting the most relevant features using feature selection and classification phases. After the patient has been detected as a COVID 19 case, the doctors must decide which patient will be provided with treatment and intensive care service. It is worth mentioned that not all cases have the same response to treatment. When there is a lack of resources, it will be mandatory to give treatment to only responding patients. For this reason, the Prediction Module(PM) is used to predict different patients' responses to COVID 19 treatment. And based on this prediction, the doctor will decide the best treatment regime for patients. Considering the lack of resources and the gradually growth of COVID19 cases, an early assessment of the patient response to treatment is essential, especially for non-responders. In addition, if . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • AIMDP model and main phase: 1
    • care service and international license: 1
    • care service and non responder: 1
    • cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and main phase: 1
    • classification phase and main phase: 1
    • different patient and international license: 1, 2, 3
    • different patient and main module: 1
    • different patient and non responder: 1
    • early assessment and international license: 1
    • feature selection and international license: 1, 2
    • gradually growth and international license: 1
    • gradually growth and main phase: 1
    • intensive care service and non responder: 1
    • intensive care service treatment and non responder: 1
    • intensive care service treatment provide and non responder: 1
    • international license and main phase: 1